Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS

Background: Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system. Well-established drugs used for MS patients after the first demyelinating event in the Czech Republic include glatiramer acetate (GA), interferon beta-1a (IFNβ-1a), IFN beta-1b...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavelek, Zbyšek, Sobíšek, Lukáš, Šarláková, Jana, Potužník, Pavel, Peterka, Marek, Štětkárová, Ivana, Štourač, Pavel, Mareš, Jan, Hradílek, Pavel, Ampapa, Radek, Grünermelová, Markéta, Vachová, Marta, Recmanová, Eva, Angelucci, Francesco, Halúsková, Simona, Vališ, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835499/
https://www.ncbi.nlm.nih.gov/pubmed/33510704
http://dx.doi.org/10.3389/fneur.2020.593527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835499/
https://www.ncbi.nlm.nih.gov/pubmed/33510704
http://dx.doi.org/10.3389/fneur.2020.593527

Ejemplares similares